Merck & Co. Inc. buy BiotechBee
Start price
08.11.22
/
70%
€100.60
Target price
31.01.25
€150.00
Performance (%)
5.77%
End price
05.05.23
€106.40
Summary
This prediction ended on 05.05.23 with a price of €106.40. The BUY prediction by BiotechBee finished with a performance of 5.77%. A total of €0.68 was paid as dividends for this prediction. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Merck & Co. Inc. | 2.529% | 2.529% | 20.872% | 1.152% |
| iShares Core DAX® | 0,02 % | 0,58 % | 11,67 % | 61,62 % |
| iShares Nasdaq 100 | 1,74 % | -2,06 % | 4,18 % | 88,71 % |
| iShares Nikkei 225® | 0,43 % | 10,49 % | 29,99 % | 67,05 % |
| iShares S&P 500 | 1,33 % | 0,14 % | 3,33 % | 60,86 % |
According to BiotechBee what are the pros and cons of Merck & Co. Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Merck & Co. Inc. diskutieren
Buy mit Kursziel 150,0
In the thread Trading Merck & Co. Inc.
Buy beendet

